Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Infectious Disease Testing Expected to Grow Beyond COVID-19
While COVID-19 has made the need for in vitro diagnostics (IVD) that can detect infectious diseases front and center, demand for these tests was building before the pandemic and revenues for test products will grow says a report from a major publisher of IVD market research. The industry consists of tests and related products […]
COVID-19 and 6 Other Trends Impacting the In Vitro Diagnostics (IVD) Market
“In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information Make no mistake, the in vitro diagnostics (IVD) […]
13 Recent Developments in Cell and Gene Therapy as of April 8, 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Bristol Myers Squibb, based in New York, NY, has announced that the European Commission (EC) has granted Marketing Authorization for Breyanzi (lisocabtagene maraleucel; liso-cel), its CD19-targeted chimeric antigen receptor (CAR)-T […]
Pets are Key to $3.5 Billion Veterinary Diagnostic Testing Market
“Companion animals (including dogs, cats, and horses) account for 70% of overall market, finds new report by Kalorama Information” – Kalorama Information In the global veterinary diagnostic testing market, the companion animal segment (pets and domestic animals including horses) comprises almost 70% of the $3,540 million ($3.5 billion) overall market, with the food animal segment […]
Molecular Point of Care Market Reaches 3.5 Billion
The molecular point of care market reached 3,555 million in 2021, according to Kalorama Information’s latest report. The Market and Potential for Molecular Point-of-Care. COVID-19 sales were the main driver. That is 10x growth in revenues from 2019. The COVID-19 pandemic and consistent arrival of variants are the determining factor, and the continued presence of […]
14 Recent Developments in Cell and Gene Therapy as of March 22, 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. EdiGene, a gene-editing company based in Beijing, China, has entered a non-exclusive, worldwide license agreement with Boston Children’s Hospital (BCH) for intellectual property rights covering the upregulation of fetal hemoglobin […]
VIDEO: 5 Key Trends in Cell and Gene Therapy
Learn about these 5 key trends based on research featured in Cell Therapy and Gene Therapy Markets, 2021-2031 (published Feb. 2022), a recent report by Kalorama Information Cell and gene therapy products are transforming the treatment of many acquired diseases such as cancer, diabetes, Parkinson’s disease and genetic diseases to correct defective genetic material. Additionally, […]
Veterinary Diagnostics: COVID-19 Pandemic Can’t Slow Momentum of $3.5 Billion Market
“The veterinary diagnostics market represents a fast-growing opportunity to IVD companies and others able to capitalize on the unfailing need to ensure agricultural productivity and the growth in consumer spending on companion animals.” – Kalorama Information The veterinary diagnostics market has experienced steady growth through the ravages of the pandemic and is forecast […]
11 Recent Developments in Cell and Gene Therapy as of March 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. The US Patent and Trademark Office has ruled against a patent challenge by the University of California, Berkeley (UC Berkeley) over patents awarded to the Broad Institute of MIT and […]
Tenfold Growth for $5.2 Billion Cell and Gene Therapy Market from 2021-2031
“Oncology, cardiovascular-blood and genetic conditions will be key contributors to the cell and gene therapy market’s strong performance through 2031.” – Kalorama Information It is an exciting and interesting time for companies involved in cell and gene therapy as the industry is forecast to grow tenfold between 2021 to 2031, according to leading medical […]